AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Nordhealth AS

Remuneration Information Sep 30, 2025

3676_dirs_2025-09-30_10114dc7-20c2-43b6-bb2e-e162272d159c.html

Remuneration Information

Open in Viewer

Opens in native device viewer

Nordhealth AS: Granting of performance-based options to executive management and key employees

Nordhealth AS: Granting of performance-based options to executive management and key employees

Helsinki, Finland, 30 September 2025: The board of Nordhealth AS (the "Company")

has today approved the allocation of a maximum of 7,217,260 options linked to

the Company's shares under an incentive scheme (the "Options") to members of the

Company's executive management and key employees.

The Options vest based on a combination of time-based and share price-based

performance. The time-based vesting is quarterly, over 4 years (1-year cliff).

The performance-based vesting requires a minimum of 11% annual compounding

growth in the share price from the start date (i.e. 10% or less annual growth

means no options vest). The maximum Options vest if 25% or higher compounding

share price growth has been achieved. There is a linear increase in vesting

between 10% and 25%.

The vested Options may be exercised in designated exercise windows during a five

year period subject to a possible extension of three additional years. The

settlement of the Options may consist of shares on a one-for-one basis and/or

cash at the discretion of the Company.

The following primary insiders and a close associate have been granted Options:

· Charles MacBain, CEO of the Company, was granted a maximum of 2,405,753

Options.

· Alexander Cram, CFO of the Company, was granted a maximum of 1,202,877

Options.

· A1KW B.V., a close associate of Karan Wallia, Therapy BU CEO, was granted a

maximum of 2,405,753 Options.

Please refer to the attached notifications of trading for further details.

For further information, please contact:

Charles MacBain, CEO [email protected] +44 75 3903 2200

Alexander Cram, CFO [email protected] +32 470 69 30 20

This information is subject to disclosure requirements set out in the Market

Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act

Section 5-12.

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS

company on a mission to redefine digital healthcare. We build software that

empower veterinary and therapy professionals to provide the best possible care

experiences to their patients. Our products serve more than 60,000 veterinary

and therapy professionals across 13,000 clinics and hospitals located in over 30

countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the

Nordic region and a growing presence internationally, with 400 employees working

either remotely or from offices (collaboration hubs). Visit the company's

website at nordhealth.com (http://www.nordhealth.com).

Talk to a Data Expert

Have a question? We'll get back to you promptly.